Correlation Between Karyopharm Therapeutics and Bright Minds
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Bright Minds Biosciences, you can compare the effects of market volatilities on Karyopharm Therapeutics and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Bright Minds.
Diversification Opportunities for Karyopharm Therapeutics and Bright Minds
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Karyopharm and Bright is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Bright Minds go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Bright Minds
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to generate 1.38 times more return on investment than Bright Minds. However, Karyopharm Therapeutics is 1.38 times more volatile than Bright Minds Biosciences. It trades about 0.05 of its potential returns per unit of risk. Bright Minds Biosciences is currently generating about -0.03 per unit of risk. If you would invest 70.00 in Karyopharm Therapeutics on October 14, 2024 and sell it today you would earn a total of 2.00 from holding Karyopharm Therapeutics or generate 2.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Karyopharm Therapeutics vs. Bright Minds Biosciences
Performance |
| Timeline |
| Karyopharm Therapeutics |
| Bright Minds Biosciences |
Karyopharm Therapeutics and Bright Minds Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karyopharm Therapeutics and Bright Minds
The main advantage of trading using opposite Karyopharm Therapeutics and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
| Bright Minds vs. Revelation Biosciences | Bright Minds vs. Zura Bio Limited | Bright Minds vs. Phio Pharmaceuticals Corp | Bright Minds vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |